Keyphrases
Uropathogenic E. Coli
100%
Host Response
100%
Suppressive Activity
62%
Urinary Tract Infection
50%
Toll-like
25%
Urothelial
18%
Intracellular Proliferation
18%
Surface Structure
12%
Live Attenuated Vaccine
12%
Innate Response
12%
Bladder
12%
Apoptosis
12%
Surface Normal
6%
Catheter-associated Urinary Tract Infection (CAUTI)
6%
Innate Host Response
6%
Live Vaccine
6%
Urothelial Inflammation
6%
EGF Signaling
6%
Enhanced Protection
6%
Acute Cystitis
6%
Uropathogenic Escherichia Coli
6%
Isogenic mutant
6%
Human Cell Culture
6%
Increasing Prevalence
6%
Public Health
6%
Genetic Screening
6%
TNF Signaling
6%
Antimicrobial Resistance
6%
High Incidence
6%
Novel Therapeutic Targets
6%
Therapeutic Potential
6%
Macromolecules
6%
Phosphorylation
6%
Inflammatory Response
6%
Inflammatory Mediators
6%
Infection Model
6%
Induced Apoptosis
6%
Health Relevance
6%
Receptor Signaling
6%
Novel Therapies
6%
Immunology and Microbiology
Uropathogenic Escherichia Coli
100%
Immune Response
100%
Urinary Tract
52%
Toll-Like Receptor
23%
Vaccine Efficacy
11%
Attenuated Vaccine
11%
Tumor Necrosis Factor
11%
Surface Property
11%
Live Vaccine
11%
Antimicrobial Resistance
5%
Inflammation Response
5%
Bladder Tissue
5%
Human Cell Culture
5%
Prevalence
5%
Mediator
5%
Macromolecule
5%
Biochemistry, Genetics and Molecular Biology
Immune Response
100%
Uropathogenic Escherichia Coli
100%
Toll-Like Receptor
23%
Surface Property
11%
Tumor Necrosis Factor
11%
Genetic Screen
5%
Anabolism
5%
Mediator
5%
Prevalence
5%
Macromolecule
5%
Human Cell Culture
5%
Antibiotic Resistance
5%
Eicosanoid Receptor
5%
Kinase
5%
Phosphotransferase
5%